Results of Clinical Study Showing That JW 100 Significantly Reduces ISGA Score in Atopic Dermatitis (AD) Published

https://pubmed.ncbi.nlm.nih.gov/34056830/ JUPITER, FL / June 22, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced the publication of clinical study results to investigate the safety and efficacy of JW-100 its proprietary lotion formulation for the treatment of atopic dermatitis (eczema). J Cosmet Dermatol 2021 May 31: Online ahead of print. The peer-reviewed publication reports on a […]

Jupiter Wellness Licenses Patents for the Treatment of Contact Dermatitis

JUPITER, FL / June 17, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced a licensing agreement for two patents covering the use of Aspartame for the treatment of Contact Dermatitis. The Agreement signed with the Oklahoma Medical Research Foundation is for a license to two issued patents, US, 7,288,527 and US 7,816,327 which cover the […]